// App-Quantinova.ai

Su1230 : Venous Thromboembolism Prophylaxis Use in Patients Admitted With Severe Ulcerative Colitis

Researchers

Presenter

  • Byron P. Vaughn

Principal Investigators

  • Alan C. Moss

  • Adam S. Cheifetz

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Venous thrombosis

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Argatroban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved